tirzepatide cv outcomes trial Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Cardiovascular Outcomes in Adults With
Description
The metallic taste during weeks 3-4 may influence food preferences, with some patients finding that certain foods taste different or less appealing than usual
If this describes your situation and youre taking Ozempic, you need to make a clear decision
Individual susceptibility varies considerably
Id ask questions like how long theyd been taking that dose, what their side effects were, and then we would come to a decision together about what dose to start
The trial duration was 12 months, with assessments conducted at baseline, 6 months, and 12 months
The entire process takes around 20 weeks
